$ハート・テスト・ラボラトリー(HSCS.US)$Heartsciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-Ecg
4
3
報告
102765799 :
what would you think, how high might it get?
Trytosaveabitスレ主102765799:
It’s hard to say because its EU patent! It most times don’t carry as much weight with market as a USA patent would! Have to see?
$ハート・テスト・ラボラトリー(HSCS.US)$• Further clinical validation of MyoVista technology from a peer-reviewed publication with data demonstrating that screening for heart disease in diabetic patients using a MyoVista AI-ECG model significantly outperformed conventional screening standards of care. Diabetes represents a major risk factor for heart disease and affects approximately 500 million people worldwide; • Significantly improved financial position. The Q3 FY2024 sharehol...
ハート・テスト・ラボラトリーに関するコメント
• Significantly improved financial position. The Q3 FY2024 sharehol...
まだコメントはありません